Drugs / Anti-Influenza Immune Plasma
Anti-Influenza Immune Plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01052480 | Dec 2010 → Mar 2015 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-Influenza Immune Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01052480 ↗ |
| Modality | Protein / enzyme biologic | “plasma with high titer anti-influenza A or anti-influenza B antibodies” NCT01052480 ↗ |